Outcomes of Estrogen Receptor Negative and Progesterone Receptor Positive Breast Cancer

• Melissa Chan,

  Affiliations Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada, Department of Medicine, University of Toronto, Toronto, ON, Canada

  ⨯
• Martin C. Chang,

  Affiliations Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada, Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada

  ⨯
• Rosa González,

  Affiliation Escuela de Enfermeria, Universidad de Salamanca, Salamanca, Spain

  ⨯
• Belinda Lategan,

  Affiliations Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada, Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada

  ⨯
• Elvira del Barco,

  Affiliation Medical Oncology Department, Salamanca University Hospital, Salamanca, Spain

  ⨯
• Francisco Vera-Badillo,

  Affiliations Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada, Department of Medicine, University of Toronto, Toronto, ON, Canada

  ⨯
• Paula Quesada,

  Affiliation Medical Oncology Department, Salamanca University Hospital, Salamanca, Spain

  ⨯
• Robyn Goldstein,

  Affiliation Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada

  ⨯
• Ignacio Cruz,

  Affiliation Servicio de Cardiología, Complejo Hospitalario de Salamanca, Salamanca, Spain

  ⨯
• Alberto Ocana,

  Affiliation Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain

  ⨯
• Juan J. Cruz,

  Affiliation Medical Oncology Department, Salamanca University Hospital, Salamanca, Spain

  ⨯
• Eitan Amir

  * E-mail: eitan.amir@uhn.ca

  Affiliations Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada, Department of Medicine, University of Toronto, Toronto, ON, Canada

  ⨯